Načítá se...
Denosumab for the Treatment of Osteoporosis
INTRODUCTION: Low trauma fractures due to osteoporosis are a major health concern worldwide. Despite the availability of many therapeutic compounds to reduce fracture risk, osteoporosis remains undertreated and the burden of osteoporotic fractures remains high. Denosumab is a novel agent that acts t...
Uloženo v:
| Vydáno v: | Expert Opin Drug Metab Toxicol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480604/ https://ncbi.nlm.nih.gov/pubmed/25614274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425255.2015.1000860 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|